AlzeCure Pharma

Legal / IP

AlzeCure Pharma’s Alzheimer’s Drug Candidate ACD856 Receives Global Patent Awards

Fineline Cube Mar 4, 2024

AlzeCure Pharma, a Swedish pharmaceutical company, has announced the receipt of patent approval awards for...

Company Deals

Lilly’s Acquisition of Innovent Biologics Wins FTC Approval – $3+ Billion Deal Clears Key Regulatory Hurdle

Company Drug

Alphamab Oncology Doses First Patient in Phase III KN026 Study – Bispecific HER2 Antibody Targets Adjuvant Breast Cancer

Others

Gilead to Acquire Ouro Medicines for $2.175 Billion – Keymed Biosciences Secures $320 Million from CM336 TCE Deal

Company Drug

Shenzhen Salubris Wins NMPA Approval for SAL0150 – Oral Long-Acting Diabetes/Obesity Drug Targets Weekly Dosing Regimen